Endovascular or surgical popliteal aneurysms exclusion – both with good results but for different patients.

Original title: A Multicentric Experience with Open Surgical Repair and Endovascular Exclusion of Popliteal Artery Aneurysms. Reference: R. Pulli et al. European Journal of Vascular and Endovascular Surgery, Volume 45, Issue 4, Pages 357-363.

 

Complications of a popliteal aneurysm may cause rupture, distal embolization or thrombosis with a risk of any of them affecting the lower limb. That’s why elective treatment of asymptomatic aneurysms larger than 20 mm is recommended. The surgery has good results although recently the possibility of endovascular stent graft exclusion has also emerged.

This retrospective multicenter registry analyzed the results of 312 popliteal aneurysms (178 treated with surgery and 134 endovascular) over a period of ten years. 

The choice of strategy was at the discretion of the treating physicians, although there were clear differences especially in the clinical presentation. The 71% treated as endovascular were asymptomatic. The opposite was true for those who received surgical treatment where 64.5% were symptomatic of claudication or acute ischemia. In the endovascular group stent grafts were used, (Hemobahn or Viabahn, WL Gore & Associates Inc, Flagstaff, AZ, USA), implanted most frequently by ipsilateral access. In the surgical group thrombosis was observed in six patients (3.3%), three of which could be resolved but the other three required major amputation. After follow-up at 12, 24 and 48-months, primary patency of this group was 78.8%, 77.1% and 63.4% respectively.  In the endovascular group seven patients developed thrombosis,  (9.7%), all could be resolved except for one patient who required major amputation. Primary patency of endovascular treatment at 12, 24 and 48 months was 79.1%, 76.9% and 73.4% respectively.

Conclusion:

In this study, which has the highest record of popliteal aneurysms, surgical or endovascular treatment was used in different patients, preferring the surgical strategy for acute presentation and endovascular for asymptomatic. Both strategies showed good results in the short and long term. 

Editorial comment:

You cannot directly compare the results of both strategies and the clinical presentation was often opposite. For the surgical group the results were better if used instead of autogenous vein graft. No randomized studies are currently available on this topic.

SOLACI.ORG

More articles by this author

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...